Central Pacific Bank - Trust Division’s Regeneron Pharmaceuticals REGN Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$880K	Buy	1,412 +185	+15%	+$126K	0.09%	216
2026 Q1	$948K	Sell	1,227 -170	-12%	-$130K	0.12%	179
2025 Q4	$1.08M	Sell	1,397 -35	-2%	-$23.8K	0.13%	159
2025 Q3	$805K	Buy	1,432 +275	+24%	+$155K	0.1%	207
2025 Q2	$607K	Buy	1,157 +480	+71%	+$268K	0.08%	250
2025 Q1	$429K	Sell	677 -50	-7%	-$34.4K	0.06%	293
2024 Q4	$518K	Sell	727 -10	-1%	-$8.39K	0.07%	257
2024 Q3	$775K	Sell	737 -5	-0.7%	-$5.56K	0.1%	211
2024 Q2	$780K	Hold	742	–	–	0.09%	228
2024 Q1	$719K	Buy	+742	New	+$706K	0.09%	247

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Central Pacific Bank - Trust Division's REGN Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its Regeneron Pharmaceuticals (REGN) stake by 15% in Q2 2026, buying an estimated $126K and bringing the position to 1,412 shares worth $880K. The position accounts for 0.09% of the portfolio, ranked #216.

Central Pacific Bank - Trust Division first reported a position in REGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.08M in Q4 2025. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Central Pacific Bank - Trust Division held 1,412 shares of Regeneron Pharmaceuticals worth $880K as of Q2 2026.
Central Pacific Bank - Trust Division bought 185 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $126K.
Regeneron Pharmaceuticals made up 0.09% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #216 holding.
Central Pacific Bank - Trust Division first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
Central Pacific Bank - Trust Division's Regeneron Pharmaceuticals position peaked at $1.08M in Q4 2025.
334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.